← Back to Search

Emergency Care Plans for Infants With Medical Complexity (ECAP Trial)

N/A
Waitlist Available
Led By Christian D Pulcini, MD, MEd, MPH
Research Sponsored by University of Vermont
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Age 0 to 6 months
Be younger than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up day 0 (nicu discharge) to month 12, assessed at quarterly intervals (month 3, 6, 9, 12)
Awards & highlights
No Placebo-Only Group

Summary

This trial aims to measure the impact of using an Emergency Care Action Plan (ECAP) for infants leaving the Neonatal Intensive Care Unit (NICU). The ECAP is a tool to help

Who is the study for?
This trial is for infants with complex medical needs who have been discharged from the Neonatal Intensive Care Unit (NICU). It aims to help caregivers and providers manage emergencies by using a tool called an Emergency Care Action Plan.
What is being tested?
The study tests if having an Emergency Care Action Plan (ECAP) in a child's Electronic Health Record helps reduce hospital stays and emergency visits. The ECAP's usage, acceptance, and long-term adoption are also evaluated.
What are the potential side effects?
There are no direct side effects associated with the use of an Emergency care action plan as it is not a medication or procedure but rather a management tool designed to improve emergency care.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am under 6 months old.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~day 0 (nicu discharge) to month 12, assessed at quarterly intervals (month 3, 6, 9, 12)
This trial's timeline: 3 weeks for screening, Varies for treatment, and day 0 (nicu discharge) to month 12, assessed at quarterly intervals (month 3, 6, 9, 12) for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Inpatient hospitalization
Secondary study objectives
Avoidance of ED visits
Caregiver self-efficacy
Caregiver stress
+3 more
Other study objectives
Cost
Implementation outcomes

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Emergency Care Action PlanExperimental Treatment1 Intervention
An Emergency Care Action Plan (ECAP) is a brief, pre-populated summary of suggested emergency management for children with medical complexity, embedded in the electronic health record.
Group II: Standard CareActive Control1 Intervention
The current standard of care does not include emergency care planning.

Find a Location

Who is running the clinical trial?

University of VermontLead Sponsor
278 Previous Clinical Trials
3,744,094 Total Patients Enrolled
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)NIH
2,056 Previous Clinical Trials
2,738,094 Total Patients Enrolled
Christian D Pulcini, MD, MEd, MPHPrincipal InvestigatorUniversity of Vermont Larner College of Medicine, University of Vermont Medical Center
~33 spots leftby Aug 2027